Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting, 65908-65909 [05-21661]

Agencies

• DEPARTMENT OF HEALTH AND HUMAN SERVICES
• National Institutes of Health

[Federal Register Volume 70, Number 210 (Tuesday, November 1, 2005)]
[Notices]
[Pages 65908-65909]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-21661]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of Science Policy, 
Office of the Director; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the second 
meeting of the National Science Advisory Board for Biosecurity (NSABB).
    Under authority 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established NSABB to provide advice, guidance and leadership regarding 
federal oversight of dual-use research, defined as biological research 
with legitimate scientific purposes that could be misused to pose a 
biological threat to public health and/or national security.
    The meeting will be open to the public, however, pre-registration 
is strongly recommended due to space limitations. Persons planning to 
attend should register online at https://www.biosecurityboard.gov/
meetings.asp or by calling The Hill Group (Contact: A.J. Bownas) at 
301-897-2789, ext. 100. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should indicate these requirements upon registration.

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: November 21, 2005.
    Open: 9 a.m. to 6 p.m.
    Agenda: Presentations and discussions regarding: (1) Criteria 
for defining dual-use research in the life sciences; (2) the role of 
a code of conduct for the life sciences; (3) communication of dual 
use research; (4) international perspectives on dual use research; 
(5) public comments; and (6) and other business of the Board.
    Place: The National Institutes of Health, Building 31, 6C--Room 
10, Bethesda, Maryland.
    Contact Person: Allison Chamberlain, NSABB Program Assistant, 
6705 Rockledge Drive, Bethesda, Maryland 20892, (301) 402-3090.
    This meeting will also be webcast. The draft meeting agenda and 
other information about NSABB, including information about access to 
the webcast and pre-registration, will be available at https://
www.biosecurityboard.gov/meetings.asp.
    Any member of the public interested in presenting oral comments 
at the meeting may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of an organization may submit a letter of 
intent, a brief description of the organization

[[Page 65909]]

represented and a short description of the oral presentation. Only 
one representative of an organization may be allowed to present oral 
comments. Both printed and electronic copies are requested for the 
record. In addition, any interested person may file written comments 
with the committee. All written comments must be received by 
November 7, 2005 and should be sent via e-mail to nsabb@od.nih.gov 
with ``NSABB Public Comment'' as the subject line or by regular mail 
to 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention 
Allison Chamberlain. The statement should include the name, address, 
telephone number and, when applicable, the business or professional 
affiliation of the interested person:

    Dated: October 20, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-21661 Filed 10-31-05; 8:45 am]
BILLING CODE 4140-01-M